Graham Earnings Calls
| Release date | Jun 08, 2026 |
| EPS estimate | $0.300 |
| EPS actual | $0.330 |
| EPS Surprise | 10.00% |
| Revenue estimate | 59.952M |
| Revenue actual | 67.078M |
| Revenue Surprise | 11.89% |
| Release date | Feb 06, 2026 |
| EPS estimate | $0.170 |
| EPS actual | $0.310 |
| EPS Surprise | 82.35% |
| Revenue estimate | 52.355M |
| Revenue actual | 56.701M |
| Revenue Surprise | 8.30% |
| Release date | Nov 07, 2025 |
| EPS estimate | $0.280 |
| EPS actual | $0.310 |
| EPS Surprise | 10.71% |
| Revenue estimate | 57.55M |
| Revenue actual | 66.027M |
| Revenue Surprise | 14.73% |
| Release date | Aug 04, 2026 |
| EPS estimate | $0.360 |
| EPS actual | - |
| Revenue estimate | 65.604M |
| Revenue actual | - |
| Expected change | +/- 9.42% |
Last 4 Quarters for Graham
Below you can see how GHM performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 04, 2026 |
| Price on release | - |
| EPS estimate | $0.360 |
| EPS actual | - |
| Date | Price |
|---|---|
| Jun 16, 2026 | $113.45 |
| Jun 17, 2026 | $115.89 |
| Jun 18, 2026 | $110.73 |
| Jun 22, 2026 | $107.91 |
| Jun 23, 2026 | $109.77 |
| Release date | Nov 07, 2025 |
| Price on release | $62.36 |
| EPS estimate | $0.280 |
| EPS actual | $0.310 |
| EPS surprise | 10.71% |
| Date | Price |
|---|---|
| Nov 03, 2025 | $62.28 |
| Nov 04, 2025 | $61.97 |
| Nov 05, 2025 | $63.95 |
| Nov 06, 2025 | $62.14 |
| Nov 07, 2025 | $62.36 |
| Nov 10, 2025 | $62.06 |
| Nov 11, 2025 | $59.49 |
| Nov 12, 2025 | $60.90 |
| Nov 13, 2025 | $58.15 |
| 4 days before | 0.128% |
| 4 days after | -6.75% |
| On release day | -0.481% |
| Change in period | -6.63% |
| Release date | Feb 06, 2026 |
| Price on release | $83.24 |
| EPS estimate | $0.170 |
| EPS actual | $0.310 |
| EPS surprise | 82.35% |
| Date | Price |
|---|---|
| Feb 02, 2026 | $73.28 |
| Feb 03, 2026 | $76.19 |
| Feb 04, 2026 | $73.19 |
| Feb 05, 2026 | $73.75 |
| Feb 06, 2026 | $83.24 |
| Feb 09, 2026 | $85.06 |
| Feb 10, 2026 | $89.11 |
| Feb 11, 2026 | $88.27 |
| Feb 12, 2026 | $83.88 |
| 4 days before | 13.59% |
| 4 days after | 0.769% |
| On release day | 2.19% |
| Change in period | 14.47% |
| Release date | Jun 08, 2026 |
| Price on release | $95.34 |
| EPS estimate | $0.300 |
| EPS actual | $0.330 |
| EPS surprise | 10.00% |
| Date | Price |
|---|---|
| Jun 02, 2026 | $106.11 |
| Jun 03, 2026 | $103.87 |
| Jun 04, 2026 | $107.96 |
| Jun 05, 2026 | $107.10 |
| Jun 08, 2026 | $95.34 |
| Jun 09, 2026 | $100.28 |
| Jun 10, 2026 | $96.06 |
| Jun 11, 2026 | $103.00 |
| Jun 12, 2026 | $103.89 |
| 4 days before | -10.15% |
| 4 days after | 8.97% |
| On release day | 5.18% |
| Change in period | -2.09% |
Graham Earnings Call Transcript Summary of Q1 2026
Graham reported a strong start to fiscal 2026: revenue rose 11% to $55.5M, adjusted EBITDA increased 33% to $6.8M (12.3% margin), and gross margin expanded to 26.5%. Orders were $126M in the quarter, producing a book-to-bill of 2.3x and driving backlog to a record ~$483M (up 22% YoY), ~87% of which is defense-related; management expects ~35%–40% of backlog to convert to revenue over the next 12 months. Key wins include follow-on awards for the Virginia-class submarine program (total $136.5M) and a recent $25.5M MK48 Mod 7 torpedo order (to be booked in Q2). Aftermarket sales were strong (+33% YoY), supporting margin expansion. Strategic and capital investments continue: a 30,000 sq ft Batavia facility (certificate of occupancy received; expected fully operational by end of calendar Q3) with automated welding installed, a cryogenic propellant testing facility in Florida expected to be operational this quarter, and ERP implementation planned by year-end. Graham received partner/customer funding (notably a $2.2M strategic investment plus Graham’s $1.4M contribution for weld evaluation work) and continues to pursue M&A opportunistically to supplement targeted organic growth (8%–10%). Balance sheet: $10.8M cash, no debt, $44.3M available on revolver; capex was $7M this quarter. Management reiterated full-year fiscal 2026 guidance (midpoint implying ~10% revenue growth and ~12% adjusted EBITDA growth) and reiterated fiscal 2027 targets of 8%–10% organic revenue growth and low- to mid-teen adjusted EBITDA margins. Key risks and items to monitor: lumpiness/timing of large defense and capital project awards, potential tariff exposure (management estimates a $2M–$5M full-year impact range), and the timing of larger global capital projects.
Sign In
Buy GHM